Overview

Retrospective Study of Patients Who Were Treated With Fondaparinux Pre-, Peri- and/or Postpartum for Prophylaxis or Treatment of Venous Thromboembolism

Status:
Completed
Trial end date:
2010-07-01
Target enrollment:
Participant gender:
Summary
The objective of this retrospective study is to gather information about how fondaparinux is used pre-, peri- and/or postpartum for both the prophylaxis and treatment of venous thromboembolism (VTE) in order to fill an information gap concerning the off-label use of fondaparinux during pregnancy.
Details
Lead Sponsor:
GlaxoSmithKline
Treatments:
Fondaparinux
PENTA